Scheme Document Requires Your Immediate Attention

Total Page:16

File Type:pdf, Size:1020Kb

Scheme Document Requires Your Immediate Attention THIS SCHEME DOCUMENT REQUIRES YOUR IMMEDIATE ATTENTION. PLEASE READ CAREFULLY. IF YOU ARE IN ANY DOUBT ABOUT THIS SCHEME DOCUMENT OR THE ACTION YOU SHOULD TAKE, YOU SHOULD CONSULT YOUR STOCKBROKER, BANK MANAGER, SOLICITOR, ACCOUNTANT, TAX ADVISER OR OTHER PROFESSIONAL ADVISER IMMEDIATELY. SCHEME SCHEME DOCUMENT CONSIDERATION DATED 27 OCTOBER 2017 S$3.38 IN CASH In relation to the proposed acquisition of Global Logistic Properties Limited (“GLP”) by Nesta Investment Holdings Limited by way of a Scheme of Arrangement FOR EACH SHARE IMPORTANT DATES AND TIMES Latest date and time for lodgement GLOBAL LOGISTIC PROPERTIES LIMITED of Proxy Form (Incorporated in the Republic of Singapore) 10.00 a.m., 27 November 2017 Company Registration No. 200715832Z Independent Financial Adviser to Date and time of Scheme Meeting Financial Adviser to the Independent Directors of Global Logistic Properties Limited Global Logistic Properties Limited 10.00 a.m., 30 November 2017 Venue of Scheme Meeting Financial Advisers to Nesta Investment Holdings Limited Hall 405, Level 4, Suntec Singapore Convention & Exhibition Centre 1 Raffles Boulevard, Suntec City, Singapore 039593 MINIMART YOUR VOTE COUNTS Please vote in person or send in your vote IMPORTANT NOTICE This Scheme Document is issued by GLP. This Scheme Document is important and requires your immediate attention. Please read it carefully. If you have sold or transferred all or any of your issued and fully paid-up ordinary shares in the capital of GLP, you should immediately hand this Scheme Document and the accompanying Proxy Form to the purchaser or transferee or to the bank, stockbroker or agent through whom you effected the sale or transfer, for onward transmission to the purchaser or transferee. The Singapore Exchange Securities Trading Limited assumes no responsibility for the correctness of any of the statements made, reports contained or opinions expressed in this Scheme Document. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. All capitalised terms shall, if not otherwise defined, have the same meanings ascribed to them in this Scheme Document. All references to dates and times are to Singapore dates and times. FFA_GLPA_GLP sschemecheme ddococ bbookook 223thOct_V5.indd3thOct_V5.indd 1 110/25/20170/25/2017 112:34:372:34:37 AAMM 1 What is the background of the transaction? What has happened? Announcement of the Strategic Review 1 December 2016 • Request received from GLP’s largest shareholder, GIC Real Estate Private Limited (“GIC”). • A Special Committee comprising four independent directors of GLP was constituted to oversee a Strategic Review, with a focus on maximising shareholder value. Conclusion of the Strategic Review 14 July 2017 • Nesta Investment Holdings Limited, which offered a Scheme Consideration of S$3.38 in cash for each Share, was selected as the preferred bidder. Kopitiam G1 All capitalised terms shall, if not otherwise defined, have the same meanings ascribed to them in this Scheme Document. All references to dates and times are to Singapore dates and times. FFA_GLPA_GLP sschemecheme ddococ bbookook 223thOct_V5.indd3thOct_V5.indd 2 110/25/20170/25/2017 112:34:462:34:46 AAMM What are the next steps? Shareholders to vote on the Scheme 30 November 2017 Details of Scheme Meeting 10.00 a.m., 30 November 2017 Hall 405, Level 4, Suntec Singapore Convention & Exhibition Centre 1 Raffles Boulevard, Suntec City, Singapore 039593 Outcome if Scheme becomes effective By 19 January 20181 • Shareholders to receive S$3.38 in cash per Share. • GLP is expected to be delisted from the SGX-ST after payment of the Scheme Consideration. 1 Refers to expected date for payment of the Scheme Consideration. Payment of the Scheme Consideration to be within seven (7) Business Days from the date the Scheme becomes effective. ** You should note that the expected date for payment of the Scheme Consideration is indicative only and may be subject to change. Please refer to future announcement(s) by the Company for the exact date of this event. All capitalised terms shall, if not otherwise defined, have the same meanings ascribed to them in this Scheme Document. All references to dates and times are to Singapore dates and times. G2 FFA_GLPA_GLP sschemecheme ddococ bbookook 223thOct_V5.indd3thOct_V5.indd 3 110/25/20170/25/2017 112:34:512:34:51 AAMM 2 Who is the Offeror? Nesta Investment Holdings Limited is owned by investment companies with a global capital investor base. Each member of the consortium understands the different elements of the logistics ecosystem. • Established by Mr. Fang Fenglei in 2008 • Leading China-based private equity investment firm, with offices in Beijing, Hong Kong and Singapore HOPU Logistics Investment Management Co., Ltd. and its affiliates and entities managed or advised • HOPU manages approximately US$8.5 billion through by them (“HOPU”) multiple funds, and has generated transactions amounting to US$33 billion in deal size • Global firm of investment professionals and operating executives focused on building and investing in high quality business franchises Hillhouse Capital Logistics Management, Ltd. • Founded in 2005, Hillhouse Capital and its group and its affiliates and entities managed or advised members manage more than US$30 billion in assets by them (“Hillhouse Capital”) on behalf of leading institutional clients globally • SMG Eastern Limited is wholly owned by Mr. Ming Z. Mei, the Chief Executive Officer and Executive Director of SMG Eastern Limited and its affiliates and the Company entities managed or advised by them • Incorporated in Hong Kong in 1984, BOCGI is the financial service investment arm of Bank of China Limited • Bank of China Group Investment Limited and BOCGI invests in Hong Kong, China and overseas, and its affiliates (“BOCGI”) focuses mainly on Bank of China Limited’s key customers, target clients and strategic partners • Established in 1984, Vanke is a leading real estate company headquartered in Shenzhen • Develops residential properties, as well as other retail and industrial properties Vanke Real Estate (Hong Kong) Company Limited (“VREHK”) and its affiliates (“Vanke”) • It conducts investment, financing and property development activities outside of China through offshore management platforms, including VREHK G3 All capitalised terms shall, if not otherwise defined, have the same meanings ascribed to them in this Scheme Document. All references to dates and times are to Singapore dates and times. FFA_GLPA_GLP sschemecheme ddococ bbookook 223thOct_V5.indd3thOct_V5.indd 4 110/25/20170/25/2017 112:34:542:34:54 AAMM 3 How does the Scheme Consideration compare to historical prices? The Scheme gives you an opportunity to realise your investment at a premium with no brokerage or trading costs. The Scheme Consideration represents a premium of approximately 81% over the Company’s 12-month volume weighted average price (“VWAP”) of S$1.87, up to and including 30 November 2016 (being the last trading day immediately prior to the date on which the Company released the announcement in respect of the undertaking of the Strategic Review). The Scheme Consideration also represents a premium of 8% over the all-time high closing price of the Shares on 24 October 2013 and 15 November 2013. If you had invested in the Company during its initial public offering, you will realise a 9.2% annualised return on your investment1 if the Scheme is successful. Scheme Consideration = S$3.38 for each Share 81% 76% 72% 67% 64% 25% 8% 22% 30% S$1.87 S$1.92 S$1.96 S$2.02 S$2.06 S$2.70 S$3.13 S$2.78 S$2.60 12 month 6 month 3 month 1 month Undisturbed Last full day All-time high Analyst NAV per VWAP2 VWAP2 VWAP2 VWAP2 price2 traded price3 closing price4 Target Share as of Price5 30 June 2017 Source: Bloomberg 1 Assuming that you re-invested all net cash dividends received over time into Shares and exit the investment at S$3.38/Share on 14 April 2018, which is the Long Stop Date. 2 Closing price as of 30 November 2016, which was the last trading day immediately before 1 December 2016, being the date on which the Company released the announcement in respect of the undertaking of the strategic review. The VWAPs are with reference to the relevant periods up to and including 30 November 2016. 3 Closing price as of 12 July 2017, being the last full trading day immediately prior to the Joint Announcement on 14 July 2017. 4 The highest closing price of the Shares, prior to the Joint Announcement on 14 July 2017, since the Company’s listing on the SGX-ST on 18 October 2010, i.e., the Closing Price of S$3.13 per Share on 24 October 2013 and 15 November 2013. 5 Average analyst 12-month target price as of 12 July 2017, based on analyst recommendations updated over the prior three (3) months. Target price range is S$1.72 – S$3.06 (Source: Bloomberg). All capitalised terms shall, if not otherwise defined, have the same meanings ascribed to them in this Scheme Document. All references to dates and times are to Singapore dates and times. G4 FFA_GLPA_GLP sschemecheme ddococ bbookook 223thOct_V5.indd3thOct_V5.indd 5 110/25/20170/25/2017 112:34:542:34:54 AAMM 4 What does the Independent Financial Adviser (“IFA”) recommend? IT IS IMPORTANT THAT YOU READ THIS EXTRACT TOGETHER WITH AND IN THE CONTEXT OF THE IFA LETTER IN FULL, WHICH CAN BE FOUND IN APPENDIX 1 TO THE SCHEME DOCUMENT. YOU ARE ADVISED AGAINST RELYING SOLELY ON THIS EXTRACT, WHICH IS ONLY MEANT TO DRAW ATTENTION TO THE CONCLUSION AND OPINION OF THE IFA. AN EXTRACT FROM THE IFA LETTER IS SET OUT BELOW: “…we are of the opinion that as of the IFA Reference Date, from a financial point of view, the Scheme Consideration is FAIR AND REASONABLE.
Recommended publications
  • CYAD JP Morgan Itinerary
    Corporate Access Event January 11 - 14, 2016 Meeting Schedule, January 11th – 14th San Francisco, CA French Biotech Co. CEO, CFO VP Business Development Strategic Advisor Immuno-Oncology Company Meeting Location: Sir Francis Drake Hotel Room # 450 P owell Street San Franc isco, CA If questions should arise, please contact: Andrew McDonald Mobile: Email: [email protected] Angela Qian Mobile: Email: [email protected] -1 Corporate Access Event January 11 - 14, 2016 MEETINGS Note: (*) indicates that this meeting time is double-booked. Meeting Time Room Meeting With Note Type Monday, January 11, 2016 08:00-09:00 am Sir Francis Drake (450 1x1 Aquilo Capital Powell St), Room 530 Patrick Rivers 09:00-10:00 am Sir Francis Drake (450 1x1 Auriga Capital Powell St), Room 530 Glen Losev 10:00-11:00 am Hotel Nikko (222 Mason 1x1 Takeda St), 25th Floor, Bay Kiran Philip View Room 11:00-12:00 pm Sir Francis Drake (450 1x1 Granite Investment Partners LAST MINUTE Powell St), Room 530 Jeffrey Hoo CANCELLATION 12:00-1:00 pm Marriott Marquis (780 1x1 AbbVie Onsite Contact: Mission St), Salon 14 Niels Emmerich Tiffany Cincotta-Janzen, (847) 393-5723 01:30-02:00 pm Sir Francis Drake (450 1x1 Alpine BioVentures, GP LLC Powell St), Room 530 David Miller 03:00-03:30 pm Sir Francis Drake (450 1x1 Tara Capital Grp Powell St), Room 530 Dhesh Govender 04:00-05:00 pm Sir Francis Drake (450 1x1 EVOLUTION Life Science Partners Powell St), Room 530 Anton Gueth Tuesday, January 12, 2016 07:00-08:30 am* Breakfast Fierce Biotech Big Data Breakfast CEO will attend.
    [Show full text]
  • Corporate Venturing Report 2019
    Corporate Venturing 2019 Report SUMMIT@RSM All Rights Reserved. Copyright © 2019. Created by Joshua Eckblad, Academic Researcher at TiSEM in The Netherlands. 2 TABLE OF CONTENTS LEAD AUTHORS 03 Forewords Joshua G. Eckblad 06 All Investors In External Startups [email protected] 21 Corporate VC Investors https://www.corporateventuringresearch.org/ 38 Accelerator Investors CentER PhD Candidate, Department of Management 43 2018 Global Startup Fundraising Survey (Our Results) Tilburg School of Economics and Management (TiSEM) Tilburg University, The Netherlands 56 2019 Global Startup Fundraising Survey (Please Distribute) Dr. Tobias Gutmann [email protected] https://www.corporateventuringresearch.org/ LEGAL DISCLAIMER Post-Doctoral Researcher Dr. Ing. h.c. F. Porsche AG Chair of Strategic Management and Digital Entrepreneurship The information contained herein is for the prospects of specific companies. While HHL Leipzig Graduate School of Management, Germany general guidance on matters of interest, and every attempt has been made to ensure that intended for the personal use of the reader the information contained in this report has only. The analyses and conclusions are been obtained and arranged with due care, Christian Lindener based on publicly available information, Wayra is not responsible for any Pitchbook, CBInsights and information inaccuracies, errors or omissions contained [email protected] provided in the course of recent surveys in or relating to, this information. No Managing Director with a sample of startups and corporate information herein may be replicated Wayra Germany firms. without prior consent by Wayra. Wayra Germany GmbH (“Wayra”) accepts no Wayra Germany GmbH liability for any actions taken as response Kaufingerstraße 15 hereto.
    [Show full text]
  • Representative Legal Matters
    Representative Legal Matters Xinxing Chen Prior to joining Baker McKenzie, Xinxing handled the following matters: Private Equity Advised Warburg Pincus on: o a number of co-investment deals with its existing limited partners and/or new investors regarding various Warburg Pincus portfolios in China and other Asia Pacific areas, including with respect to Warburg Pincus' investment in the USD 8.7 billion take-private of 58.com (NYSE: WUBA), China's largest online classifieds marketplace. o its subscription for USD 230 million convertible note issued by Uxin (NASDAQ: UXIN), a Chinese used car trading platform. Advised Cartesian Capital Group on an investment by Tencent Holdings Ltd. in Cartesian's portfolio company, Tim Hortons China, a joint venture with the Canada-based restaurant chain. Advised DCP Capital, a leading Greater China-focused private equity firm co-founded by ex-KKR professionals, on its proposed USD 200 million investment in a Chinese leading non-alcoholic beverages manufacturer. Advised KKR on: o its investment in Joulon, an integrated platform based in Dubai providing asset management services to the oil and gas industry globally, and a series of add-on acquisitions made by Joulon in its expansion. o its investment in Mandala Energy, a South East Asia focused oil and gas exploration and production company based in Singapore. Advised Bain Capital on: o its acquisition of Xiamen Qinhuai Technology Company Limited (ChinData), a leading operator of hyperscale data centers in China, from Wangsu Science & Technology Co. Ltd., as well as on the combination of ChinData with Bain Capital's existing Bridge Data Centres platform.
    [Show full text]
  • Full-Time MBA Program Class of 2015 Full-Time Employment Class of 2016 Internship Employment
    Employment Data Full-Time MBA Program Class of 2015 Full-Time Employment Class of 2016 Internship Employment som.yale.edu/employmentdata Class of 2015 Full-Time Employment Status Received Job Offer Demographic Data Three Months Post Graduation (at matriculation in fall 2013) 93.4% 228 of 244 students seeking employment Mean Age 28 Gender Accepted Job Offer Three Months Post Graduation Female 39% 92.2% Male 61% 225 of 244 students seeking employment U.S. Minority 23% Class Size 278 Underrepresented Minority 10% Students Seeking Employment 244 87.8% Country of Origin Students Not Seeking Employment 31 11.2% United States 68% Starting Own Business 15 5.4% International 32% Company Sponsored 11 4.0% Average GMAT 714 Continuing Education 3 1.1% Average GPA 3.57 Postponing Search/Other 2 0.7% No Response to Survey 3 1.1% Full-Time Salary Data Overall Salary Data Base Salary1 Other Guaranteed Compensation2 25th Median 75th 25th Median 75th Percentile Percentile Percentile Percentile $105,000 $120,000 $130,000 $25,000 $34,616 $51,750 Salary by Function Base Salary1 Other Guaranteed Compensation2 Percent 25th Median 75th 25th Median 75th of Hires3 Percentile Percentile Percentile Percentile Consulting Services 37.1% $112,750 $135,000 $140,000 $25,000 $30,000 $39,000 External Consulting 28.6% $122,500 $135,000 $140,000 $25,000 $30,000 $39,250 Internal Consulting/Strategy 8.5% $85,000 $110,000 $122,500 $7,000 $27,475 $37,875 Finance/Accounting 30.4% $105,000 $122,344 $125,000 $28,000 $50,000 $60,000 Marketing/Sales 13.4% $100,000 $112,000 $117,000
    [Show full text]
  • History, Reorganization and Corporate Structure
    THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT INFORMATION MUST BE READ IN CONJUNCTION WITH THE SECTION HEADED “WARNING” ON THE COVER OF THIS DOCUMENT. HISTORY, REORGANIZATION AND CORPORATE STRUCTURE OVERVIEW We are the largest digital medical service platform in China in terms of both the number of Internet hospitals as of December 31, 2020 and volume of digital medical consultations provided in 2019, according to Frost & Sullivan. Guided by our principle of “your health, we care” (“您的健康,我們的責任”), our vision is to establish the largest digital service platform in the world driven by technology and innovation to empower people to live healthier. Our Group was founded by Mr. Liao, the chairman of the Board, executive Director and the CEO of our Company. For the biography and industry experience of Mr. Liao, please refer to the section headed “Directors and Senior Management” in this Document. Our Group was established in 2004. In preparation for the [REDACTED], we conducted the Reorganization, details of which are set out in the sub-section headed “Reorganization” in this section. BUSINESS MILESTONES The following is a summary of our key business development milestones since our inception in 2004: Year Event 2004 Our Company was incorporated in the BVI 2006 Our Company registered by way of continuation in the Cayman Islands 2011 Our Company launched guahao.com, an online doctor appointment platform, in the PRC 2015 We upgraded our brand name from “guahao.com” to “We Doctor” We established Wuzhen Internet Hospital in Wuzhen, China, which was the first Internet hospital in the PRC 2017 We opened our first Internet hospital service center 2018 We launched our “mobile hospital” services empowered by our Internet hospital We established We Doctor Taishan Chronic Disease Internet Hospital, which was the first Internet hospital focusing on CDM in the PRC – 188 – THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT INFORMATION MUST BE READ IN CONJUNCTION WITH THE SECTION HEADED “WARNING” ON THE COVER OF THIS DOCUMENT.
    [Show full text]
  • Institutional Asset Management in Asia 2020
    PRODUCT DETAILS Included with Purchase y Institutional Asset Management in Asia 2020 y Digital report in PDF format Key findings Setting the Stage for a New Era y Unlimited online firm-wide access y Analyst support y Exhibits in Excel y Interactive Report Dashboards OVERVIEW & METHODOLOGY This report takes a comprehensive examination of the Asia-Pacific region’s institutional Interactive Report landscape and outsourcing opportunities for external asset managers. It builds on our Dashboards previous research on Asian pensions, sovereign wealth funds, insurers, and other institutions, Interact and explore select and complements all our other Asian publications. The report focuses on market sizing and report data with Cerulli’s addressability, institutions’ investment behavior, strategies and allocation plans, outsourcing visualization tool. practices, manager selection, use of consultants, and other trends in Asia’s institutional asset management industry. The report explores three region-wide themes—the evolution of institutional sales, demand for alternative strategies, and de-risking and liquidity management among institutions. It y Regional Overview: Compare institutional market sizing in the also assesses the opportunities and challenges in the Australia and New Zealand institutional Asia-Pacific region, which includes investable assets by market, markets. This is followed by in-depth analysis of the institutional markets of China, Hong Kong, year, and institution type, as well as forecasted investable and Japan, Korea, Singapore, and Taiwan. addressable assets. y Institutional Type Analysis: Evaluate and compare the USE THIS REPORT TO retirement, insurance, and sovereign wealth fund markets in Asia ex-Japan, with interactive data covering investable and addressable y Analyze insourcing and fintech adoption trends among Asian institutions and how managers assets segmented by year, investment objective, and asset class.
    [Show full text]
  • Proptech Global Trends 2020 Annual Barometer 2 - Proptech Global Trends 2021 Barometer the Global Proptech Industry
    1 - PropTech Global Trends 2021 Barometer The Global PropTech Industry PropTech Global Trends 2020 Annual Barometer 2 - PropTech Global Trends 2021 Barometer The Global PropTech Industry Content Executive Summary 3 PropTech : Investing, Building, Managing and Living in a digital world 4 What is PropTech? 4 Why does it matter? 4 Why Now? 5 PropTech Opportunities 5 PropTech Company Categories 6 The Global PropTech Industry 9 1,724 PropTech companies unequally spread in 64 countries 10 Investment and funding structure of the PropTech Industry 11 3,118 investors worldwide mainly from the US 17 Focus on the US PropTech Industry 19 An increasing number of American PropTech companies 20 Investment: an industry dominated by a few companies 24 Funding structure of American PropTech companies 27 California: the financial heart of the American PropTech industry 28 The PropTech Industry in the Rest of World 30 PropTech companies across western countries and emerging giants 31 Investment opportunities are concentrated in a few Indian and Chinese PropTech companies 32 Funding structure of non-US PropTech companies 33 Most investors are from Europe, India and China 35 3 - PropTech Global Trends 2021 Barometer The Global PropTech Industry Executive Summary The 2020 PropTech Annual Barometer is an in-depth analysis of the international Prop- Tech sector. It analyses the evolution of PropTech over time, with graphs depicting the historical evolution of PropTech since its initial emergence. The Barometer also iden- tifies the sector’s newcomers, the quality of its emerging companies, its peak periods, and the leading companies in the Tech sector. We also visualise the PropTech sector’s geography via a world map showing the locations and amount of PropTech companies per continent and country.
    [Show full text]
  • The Money Management Gospel of Yale's Endowment Guru
    The Money Management Gospel of Yale’s Endowment Guru - T... http://www.nytimes.com/2016/11/06/business/the-money-man... http://nyti.ms/2eaLzsP BUSINESS DAY The Money Management Gospel of Yale’s Endowment Guru By GERALDINE FABRIKANT NOV. 5, 2016 As he has done for decades, once a week David F. Swensen convenes his staff — including his cadre of apprentices — for a morning-long meeting among the Gothic revival flourishes and crenelations of the Yale University campus to debate investment ideas. Mr. Swensen, 62, runs the school’s $25.4 billion endowment, one of the largest in the country. Usually he is joined by his intellectual sparring partner, Dean Takahashi, his senior director. It amounts to an internship in the world of managing a university’s billions — and the young analysts have a front-row seat. “It was like watching a 70-year-old married couple go at it in full force,” recalled Andrew Golden, who was one of those Swensen acolytes in the 1980s. But forget what you think about internships and fetching doughnuts for the bosses. The meetings are supposed to be a crucible of ideas, and the analysts — some of whom stay in the positions for years — recalled bringing their own proposals in the early days, and having to defend them or face the music. “It could be jarring to have your own view shredded by them,” Mr. Golden said. As for Mr. Swensen, it’s an environment that brings together two things he loves: 1 of 9 11/30/16, 3:19 PM The Money Management Gospel of Yale’s Endowment Guru - T..
    [Show full text]
  • ANNUAL REVIEW 2018 Waking up to Impact a Recognized Leader
    ANNUAL REVIEW 2018 Waking up to impact A Recognized Leader LenderLender of of the the year Year in inEurope Europe Ares Management is a global alternative asset manager built around three scaled businesses that collaborate to consistently deliver innovative, solutions-oriented results across market cycles. credit private equity real estate www.aresmgmt.com | www.arescapitalcorp.com The performance, awards/ratings noted herein may related only to selected funds/strategies and may not be representative of any client’s given experience and should not be viewed as indicative of Ares’ past performance or its funds’ future performance. REF: AM-00162 AresFullpageAds_Artwork.indd 2 2/12/19 11:50 AM Impact is everything ISSN 1474–8800 MARCH 2019 injected extra impetus into the movement, but TOBY Senior Editor, Private Equity MITCHENALL has also raised questions about definition. Who Toby Mitchenall, Tel: +44 207 566 5447 EDITOR'S [email protected] LETTER should be allowed to raise capital under the Senior Special Projects Editor “impact” label? It is currently a broad church, Graeme Kerr, Tel: +44 203 862 7491 [email protected] housing everything from philanthropically- Senior Editor, Private Equity, Americas driven capital that does not require “market” Isobel Markham, Tel: +1 646 380 6194 [email protected] returns at one end, to sleeves of existing port- Senior Reporters folios screened for their contribution to posi- Rod James, Tel: +44 207 566 5453 [email protected] tive change at the other. Carmela Mendoza, Tel: +852 2153 3148 One of our most read stories of 2018 broke the The definitional grey-ness is evident in the [email protected] news that KKR was joining the impact investing impact category of our annual awards.
    [Show full text]
  • 3Rd FCF Life Science Venture Capital Report
    FCF Life Science Research 3rd Life Science Venture Capital Report – Financing Trends in Europe and the US Fungi Penicillium Part of FCF Life Science Research Series Executive Summary FCF Overview Funding Development in 2018 Life Sciences: A closer Look C r o s s - border Investment Activity Investor Analysis Life Science Exits 2 Executive Summary The FCF Life Science Venture Capital FCF Life Science Venture Capital Report Recipients Report is a is a comprehensive, standardized analysis for biotechnology, The FCF Life Science Venture Capital Report targets the following standardized report pharmaceutical and medical technology companies, examining recipients: focusing on venture recent venture capital deal trends in the European life science ▪ Corporates / Executives ▪ Venture capital investors capital deal industry ▪ Institutional investors ▪ Family Offices / High- characteristics in the ▪ Private equity investors net-worth individuals biotechnology, ▪ Advisors Selection of Companies pharmaceutical and medical technology The selection of companies is based on the following criteria: Availability segments, and can be used as a quick ▪ Companies operating in the biotechnology, pharmaceutical, The FCF Life Science Venture Capital Report is available on FCF’s reference for medical technology, services or other life science related sectors website at “https://www.fcf.de/de/research/life-science-research“ investors, corporates ▪ Sole focus on transactions involving European life science and professionals companies Data ▪ The therapeutics sector is further divided into the following All input data is provided by Pitchbook, S&P Capital IQ or More advanced, indications: Oncology, Central Nervous System, Infectious GlobalData and is not independently verified by FCF. Ratio and detailed and / or Diseases, Immunology, Ophthalmology, Rare Diseases, multiple calculations are driven based on the input data available.
    [Show full text]
  • Private Placement Activity Chris Hastings | [email protected] | 917-621-3750 3/19/2018 – 3/23/2018 (Transactions in Excess of $20 Million)
    Private Capital Group Private Placement Activity Chris Hastings | [email protected] | 917-621-3750 3/19/2018 – 3/23/2018 (Transactions in excess of $20 million) Trends & Commentary ▪ This week, 15 U.S. private placement deals between $20 million and $50 million closed, accounting for $452 million in total proceeds, compared to last week’s 13 U.S. deals leading to $421 million in total U.S. Corporate VC Activity $ in Billions proceeds. This week also had 6 U.S. deals between $50 million and $100 million yielding $365 million, $50 compared to last week’s 5 deals resulting in $341 million in total proceeds. 1,379 ▪ U.S. corporate venture capital deal volume has grown over the past decade from $10.0 billion in 2008 to $45 1,283 1,268 $37.4 billion in 2017. The number of deals has increased as well, from 674 in 2008 to 1,268 in 2017. (see 1,231 $40 figure) ▪ Dropbox priced its IPO at $21 per share and traded up 40% on its opening to close at $28.48 a share. The $35 1,045 Company raised $756 million and had an initial market cap of more than $8.0 billion. Dropbox previously raised $350 million in Series C funding at a $9.7 billion pre-money valuation from BlackRock in 2014. $30 829 713 ▪ Zscaler, a provider of a global cloud security platform, priced its IPO last week at $27.50 per share, raising $25 674 $192 million. The Company had originally planned to sell 10 million shares between $10 and $12 a share.
    [Show full text]
  • CVC Infographic May 2021
    CORPORATE VENTURE CAPITAL (CVC) NEWSLETTER CVC in Numbers Key News 12- MAY - 2 0 2 1 CVC Deals Overview Total count of investors CloudWalk obtains $190 million in series B funding (CVC involved: FIS Ventures) • Brazil-based open payment networking platform CloudWalk has received $190 million in a series B funding round, bringing the company's total funds raised to $206 million • The funding was led by Coatue Management with participation from DST Global, FIS Ventures, 282 218 The Hive Brazil and Valor Capital • The obtained fund will largely be used for business expansion in Brazil. The platform has processed payments worth more than $1 billion and has a network of ~70,000 merchants in Largest deal size 3,300 cities accessible to more than 4.6 million consumers 12 MAY 2 0 2 1 Health technology start-up Huma secures $130 million funding (CVC involved: Hitachi $610 million Ventures, Leaps by Bayer, Sony Innovation Fund and Unilever Ventures) • Huma Therapeutics Limited has announced series C venture funding of $130 million, which includes $100 million as equity and $30 million in credit • The funding round was led by Leaps by Bayer and Hitachi Ventures. Other investors that Leading Targets and Investors participated in the round include Samsung Next, Sony Innovation Fund by IGV (one of Sony’s investment funds), Unilever Ventures and HAT Technology & Innovation Fund, Nikesh Arora (the former president of SoftBank and ex-Google exec) and Michael Diekmann (Chairman of Allianz) • Huma uses AI, digital biomarkers and real-time data to monitor patients. It also assists Leading companies Leading investors researchers and pharmaceutical companies in running clinical trials.
    [Show full text]